BIOMARIN PHARMACEUTICAL INC Unrealized Gain (Loss) on Investments
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Unrealized Gain (Loss) on Investments of -$69.00 thousand for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-10-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2011-10-31
- BIOMARIN PHARMACEUTICAL INC unrealized gain (loss) on investments for the quarter ending 2011-09-30 was $687.00K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2011-09-30 | $687.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | -$69.00K 10-Q · filed 2011-10-31 | ||
| 2011-06-30 | -$756.00K 10-Q · filed 2011-08-01 | |||
| 2010-12-31 | -$662.00K 10-Q · filed 2011-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |